New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus
Castle Biosciences announced publication of a study showing TissueCypher changed clinician management recommendations in 90% of non-dysplastic Barrett's esophagus patients at Keck Medicine of USC. In the 30-patient case series, all intermediate- or high-risk patients had management escalated, while management was de-escalated for 84% of low-risk patients; results changed management or increased physician confidence in 97% of cases.
Key figures
- Study cohort size
- 30
- Deescalation low risk
- 84%
- Confidence change rate
- 97%
- Management change rate
- 90%
- Patients classified low risk
- 83%
- Patients classified intermediate high risk
- 17%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.